Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol HFA in infants with acute wheezing
NCT00144846Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2004
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Albuterol Sulfate HFA with Placebo HFA (2 arms). Primary endpoint: Safety of cumulative dosing of albuterol sulfate inhalation aerosol. Started Sep 2004; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00144846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144846.